Market Overview:
The global Zika virus market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing incidence of Zika virus, rising awareness about the disease, and technological advancements in diagnostic tests. However, lack of awareness among people in developing countries is likely to restrain the growth of this market during the forecast period. Based on type, sexual transmission accounted for a major share of the global Zika virus market in 2017. This segment is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. This can be attributed to increasing incidence rates of sexually transmitted diseases (STDs) across different regions. Blood transfusion was another key segment in this market and accounted for a significant share in 2017.
Product Definition:
Zika virus is a flavivirus that is closely related to dengue virus. It was first isolated from a rhesus monkey in the Zika Forest of Uganda in 1947. The name of the virus comes from the forest where it was discovered. Transmission of Zika virus occurs through bites from infected Aedes mosquitoes, which can also transmit other viruses such as dengue and chikungunya.
Sexual Transmission:
The term sexual transmission is used to define the transfer of pathogens from one individual to another through sexual fluids or contact with an infected person. It can be defined as the movement of disease from one individual to another through sex, semen, vaginal fluid, or blood. The most common ways that diseases are spread is by direct contact with an infectious agent (such as a virus) and via air-borne route (inhalation).
Blood Transfusion:
Blood transfusion is the process of replacing blood lost from a patient's body. It is done during an emergency when a patient has lost too much blood or when the body cannot produce enough blood on its own. Blood transfusions are classified as red cell, white cell, and platelet transfusions depending upon their source and function. The most common reason for blood transfusion is hemorrhage (bleeding).
Application Insights:
Based on application, the market is segmented into hospitals, clinics, ambulatory surgery centers (ASCs), others and blood transfusion. Hospitals held the largest share of over 70.0% in 2017 owing to high prevalence of target population and rapid spread across various regions. In addition, growing number of hospital admissions for dengue hemorrhagic fever is expected to drive demand for Zika virus testing at hospitals during 2018-19 period.
Clinics are anticipated to be fastest-growing segment due to rising awareness about prevention measures taken by governments across the globe regarding this disease along with increasing travel activities by patients from different parts of the world including Asia Pacific.
Regional Analysis:
North America dominated the market in 2017. The presence of a strong healthcare infrastructure and high awareness levels coupled with the quick adoption of advanced technologies are some factors responsible for its large share. Moreover, sexual transmission accounted for majority of cases in this region, which is expected to boost demand over the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to increasing number of Zika virus infections especially in countries such as India, Indonesia, and China among others.
Growth Factors:
- Increasing global population and travel: The number of people travelling to Zika-affected areas is increasing every year, thereby exposing more people to the virus.
- Uncontrolled mosquito breeding: Mosquitoes are spreading the virus rapidly due to uncontrolled breeding in many parts of the world.
- Emergence of new Zika strains: The virus is mutating rapidly, leading to emergence of new strains that are difficult to detect and treat.
- Limited vaccine availability: There is no vaccine available for Zika yet, which is hampering efforts to contain the spread of the virus.
Scope Of The Report
Report Attributes
Report Details
Report Title
Zika Virus Market Research Report
By Type
Sexual Transmission, Blood Transfusion,
By Application
Hospitals, Clinics, Ambulatory Surgery Centers, Others,
By Companies
Bharat Biotech, Inovio Pharmaceuticals and GeneOne Life Sciences, Intrexon, Cerus, Sanofi, NewLink Genetics, Immunovaccine, GlaxoSmithKline
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
235
Number of Tables & Figures
165
Customization Available
Yes, the report can be customized as per your need.
Global Zika Virus Market Report Segments:
The global Zika Virus market is segmented on the basis of:
Types
Sexual Transmission, Blood Transfusion,
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Ambulatory Surgery Centers, Others,
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bharat Biotech
- Inovio Pharmaceuticals and GeneOne Life Sciences
- Intrexon
- Cerus
- Sanofi
- NewLink Genetics
- Immunovaccine
- GlaxoSmithKline
Highlights of The Zika Virus Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Sexual Transmission
- Blood Transfusion
- By Application:
- Hospitals
- Clinics
- Ambulatory Surgery Centers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Zika Virus Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Zika virus is a mosquito-borne virus that can cause severe birth defects if contracted by pregnant women. It was first identified in Uganda in 1947 and has since been found in many parts of the world. The most common symptoms are fever, rash, joint pain, and conjunctivitis (red eyes). Zika is also associated with Guillain-Barru00e9 syndrome (GBS), a rare neurological disorder that can lead to paralysis. There is currently no vaccine or treatment available for Zika virus infection.
Some of the major players in the zika virus market are Bharat Biotech, Inovio Pharmaceuticals and GeneOne Life Sciences, Intrexon, Cerus, Sanofi, NewLink Genetics, Immunovaccine, GlaxoSmithKline.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Zika Virus Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Zika Virus Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Zika Virus Market - Supply Chain
4.5. Global Zika Virus Market Forecast
4.5.1. Zika Virus Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Zika Virus Market Size (000 Units) and Y-o-Y Growth
4.5.3. Zika Virus Market Absolute $ Opportunity
5. Global Zika Virus Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Zika Virus Market Size and Volume Forecast by Type
5.3.1. Sexual Transmission
5.3.2. Blood Transfusion
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Zika Virus Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Zika Virus Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Clinics
6.3.3. Ambulatory Surgery Centers
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Zika Virus Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Zika Virus Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Zika Virus Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Zika Virus Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Zika Virus Demand Share Forecast, 2019-2026
9. North America Zika Virus Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Zika Virus Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Zika Virus Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Ambulatory Surgery Centers
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Zika Virus Market Size and Volume Forecast by Type
9.7.1. Sexual Transmission
9.7.2. Blood Transfusion
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Zika Virus Demand Share Forecast, 2019-2026
10. Latin America Zika Virus Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Zika Virus Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Zika Virus Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Ambulatory Surgery Centers
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Zika Virus Market Size and Volume Forecast by Type
10.7.1. Sexual Transmission
10.7.2. Blood Transfusion
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Zika Virus Demand Share Forecast, 2019-2026
11. Europe Zika Virus Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Zika Virus Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Zika Virus Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Ambulatory Surgery Centers
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Zika Virus Market Size and Volume Forecast by Type
11.7.1. Sexual Transmission
11.7.2. Blood Transfusion
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.0.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Zika Virus Demand Share, 2019-2026
12. Asia Pacific Zika Virus Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Zika Virus Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Zika Virus Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Ambulatory Surgery Centers
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Zika Virus Market Size and Volume Forecast by Type
12.7.1. Sexual Transmission
12.7.2. Blood Transfusion
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Zika Virus Demand Share, 2019-2026
13. Middle East & Africa Zika Virus Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Zika Virus Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Zika Virus Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Ambulatory Surgery Centers
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Zika Virus Market Size and Volume Forecast by Type
13.7.1. Sexual Transmission
13.7.2. Blood Transfusion
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Zika Virus Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Zika Virus Market: Market Share Analysis
14.2. Zika Virus Distributors and Customers
14.3. Zika Virus Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Bharat Biotech
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Inovio Pharmaceuticals and GeneOne Life Sciences
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Intrexon
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Cerus
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Sanofi
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. NewLink Genetics
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Immunovaccine
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. GlaxoSmithKline
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
